期刊文献+

帕金森病患者血尿酸水平测定及其意义 被引量:2

下载PDF
导出
摘要 目的探讨血尿酸水平与帕金森病(PD)的关系。方法对符合入选标准的患者分入PD组(67例),并按病情分级,同时收集同期与PD组在年龄、性别构成相匹配的健康体检者作为对照组(67例)。两组均测定空腹静脉血尿酸值,两组比较选择t检验,多组间比较选择方差分析q检验,相关关系用Spearman等级相关分析。结果PD组血尿酸水平低于对照组(P<0.05),两组不同性别血尿酸水平对比差异无显著性(P>0.05)。血尿酸水平与PD患者的病情轻重无明显相关性(r=0.13)。结论血尿酸水平与PD有一定的关系,低血尿酸水平可能是PD发病的危险因素,但其程度尚不是反映PD患者病情轻重的指标。
出处 《广东医学》 CAS CSCD 北大核心 2008年第9期1491-1492,共2页 Guangdong Medical Journal
  • 相关文献

参考文献9

  • 1JENNER P, OLANOW C W. Oxidative stress and the pathogenesis of Parkinson' s disease[J]. Neurology, 1996, 47 : S161 - S170.
  • 2JENNER P. Oxidative stress in Parkinson' s disease [ J ]. Ann Neurol, 2003, 53 ( Suppl 3 ) : S26 - S36.
  • 3DE LAU L M, KOUDSTAAL P J, HOFMAN A, et al. Serum uric acid levels and the risk of Parkinson disease[J]. Ann Neurol,2005, 58 (5) : 797 - 800.
  • 4WEISSKOPF M G, O' REILLY E, CHEN H, et al. Plasma urate and risk of Parkinson' s disease[J]. Am J Epidemiol, 2007, 166 (5) : 561 -567.
  • 5MEARA J, BHOWMICK B K, HOBSON P. Accuracy of diagnosis in patients with presumed Parkinson' s disease [ J ]. Age Ageing, 1999, 28(2) : 99 -102 .
  • 6DAN W, LADENHEIM B, CUTLER R G, et al. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson' s disease [ J ]. J Neurochem, 2002, 80(1) : 101 -110.
  • 7GHIO A J, FORD E S, KENNEDY T P, et al. The association between serum ferritin and uric acid in humans[J]. Free Radic Res, 2005, 39 : 337 - 342.
  • 8惠红霞,李作孝,陈秀,陈忠伦,佟琳.多发性硬化患者血清尿酸水平变化的研究[J].临床神经病学杂志,2004,17(4):250-252. 被引量:3
  • 9ANNANMAKI T, MUURONEN A, MURROS K. Low plasma uric acid level in Parkinson' s disease [ J ]. Mov Disord, 2007, 22 (8): 1 133-1 137.

二级参考文献10

  • 1Poser CM,Paty DW,Scheinberg L,et al.New diagnostic criteria for multiple sclerosis:guidelines for research protocols.Ann Neurol,1983,13:2273
  • 2Hooper DC,Scott GS,Zborek A,et al.Uric acid,a peroxynitrite scavenger,inhibits CNS inflammation,blood-CNS barrier permeability changes,and tissue damage in a mouse model of multiple sclerosis.FASEB J,2000,14:691
  • 3Touil T,Deloire-Grassin MS,Vital C,et al.In vivo damage of CNS myelin and axons induced by peroxynitrite.Neuroreport,2001,12:3637
  • 4Toncev G,Milicic B,Toncev S,et al.Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.Eur J Neurol,2002,9:221
  • 5Drulovic J,Dujmovic I,Stojsavljevic N,et al.Uric acid levels in sera from patients with multiple sclerosis.J Neurol,2001,248:121
  • 6Spitsin S,Hooper DC,Leist T,et al.Inactivation of peroxynitrite in multiple sclerosis patients after oral administration of inosine may suggest possible approaches to therapy of the disease.Mult Scler,2001,7:313
  • 7Sotgiu S,Pugliatti M,Sanna A,et al.Serum uric acid and multiple sclerosis.Neurol Sci,2002,23:183
  • 8Keles MS,Taysi S,Aksoy H,et al.The effect of corticosteroids on serum and cerebrospinal fluid nitric oxide levels in multiple sclerosis.Clin Chen Lab Med,2001,39:827
  • 9Rosenberg GA,Dencoff JE,Correa N Jr,et al.Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis:relation to blood-brain barrier injury.Neurology,1996,46:1626
  • 10Koprowski H,Spitisin SV,Hooper DC,et al.Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid,a scavenger of peroxynitrite.Ann Neurol,2001,49:139

共引文献2

同被引文献5

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部